C
ALB icon

Cerebellum’s Albemarle ALB Stock Holding History

Cerebellum’s Portfolio ALB Stock Details ALB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$55K Buy
+612
New +$54.2K 0.26% 309

Other funds holding ALB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cerebellum's ALB Position: Q3 2020 in Review

Cerebellum opened a new position in Albemarle (ALB) in Q3 2020: 612 shares worth $55K. The stake represents 0.26% of the portfolio and ranks #309 among its holdings.

575 funds tracked by Wall St. Rank hold ALB as of Q3 2020.

  • Cerebellum held 612 shares of Albemarle worth $55K as of Q3 2020.
  • Albemarle was a new Cerebellum position in Q3 2020.
  • Albemarle made up 0.26% of Cerebellum's portfolio in Q3 2020, its #309 holding.
  • 575 funds tracked by Wall St. Rank held Albemarle as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.